I currently hold the role of Global Product Leader for several late-stage products in the Haematology Franchise, 肿瘤学 Business Unit at AstraZeneca. The role is akin to the CEO of the product, where I lead a cross-functional team accountable for delivering on our ambition for the Haematology Franchise, bringing blood cancer patients closer to uncompromised survival and elevating our leadership position. It’s a real honor to know we are helping patients on a daily basis.
加入澳门葡京网赌游戏之前, I worked at Roche in Switzerland, where I led several strategy programmes in 肿瘤学 on the global level, including the creation of a cross-functionally integrated Lung Cancer Franchise across Pharma, Diagnostics and Digital Health. 在加入罗氏之前, I spent 15 years at AstraZeneca in several development and commercial roles across multiple geographies.
I am personally very passionate about shaping the healthcare environment to make it more sustainable and equitable. I have been elected to several industry boards and private biotech companies and hold several honourary positions outside of AstraZeneca.
我获得了工商管理硕士学位, 博士学位, MSc and Lean Sigma Master Black Belt and am a co-author of the industry renowned 5Rs publication.
For those who have been touched by the diseases we work on, it’s a real honour to be CEO of some of the most critical products in our pipeline, where we are making a meaningful difference for patients. It’s a pleasure to have the opportunity to work with dedicated and passionate people every day and push the boundaries of science together so we can all be part of AstraZeneca’s legacy of using innovative science to transform healthcare for the better.
![Headshot of 吉玛Satterthwaite, Global Product Leader, 肿瘤学 Business Unit at AstraZeneca](/content/dam/az/our-company/our-people/Gemma-Satterthwaite-headshot-v1.jpg/jcr:content/renditions/cq5dam.web.100.square.Gemma-Satterthwaite-headshot-v1.jpg)
电流的作用
2022 - present: Global Product Leader, 肿瘤学 Business Unit, AstraZeneca
2022
2020: Executive Project Team Leader, 肿瘤学, Roche
2020: Integrated Strategy Leader, Lung Cancer and 罕见的疾病 Franchise, Roche
2019
Veeva ID: Z4-50602
Date of preparation: November 2022